[Coronary bypass in treatment of high-risk patients]

Harun Avdagić1, Emir Mujanović, Nihad Mesanović

  • 1Klinika za kardiovaskularne bolesti, JZU Univerzitetski klinicki centar Tuzla, BiH. harun.avdagic@ukctuzla.ba

Medicinski Arhiv
|June 23, 2009
PubMed

Insights

Coronary artery bypass grafting (CABG) without cardiopulmonary bypass (CPB) offers significant advantages over conventional CABG with CPB. This study found reduced complications, shorter intensive care unit stays, and less need for blood transfusions in patients undergoing off-pump CABG.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery

Context:

  • Comparative studies on coronary artery bypass surgery (CABG) with and without cardiopulmonary bypass (CPB) are globally available.
  • No such analysis has been conducted in Bosnia and Herzegovina until this study.

Purpose:

  • To compare morbidity and mortality rates between CABG performed with and without CPB.
  • To evaluate differences in the need for blood transfusions, intensive care unit (ICU) length of stay, total hospitalisation duration, and complication rates.

Summary:

  • A study compared 100 patients undergoing CABG with CPB to 100 patients undergoing CABG without CPB (off-pump CABG).
  • Off-pump CABG patients experienced shorter mechanical ventilation times (3.7 vs. 9.74 hours), reduced ICU stays (19 vs. 23 days), and less postoperative bleeding (574.9 vs. 988.9 ml).
  • The off-pump group also required less intraoperative and postoperative inotropic support, and had a shorter total hospitalisation duration (8.0 vs. 9.5 days).

Impact:

  • Coronary artery bypass grafting without cardiopulmonary bypass demonstrates reduced mortality and morbidity.
  • Off-pump CABG leads to a decreased need for blood transfusions and shorter recovery times, including reduced mechanical ventilation and ICU stays.
  • This approach offers significant advantages over conventional CABG with CPB, improving patient outcomes and resource utilization.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...